A. JANS PHARMA
Timeline
12 events since 2020Board
Filings
Financial
Establishments
2020202220242026
The 2026 accounts are due by 31-07-2027.
2026
Annual accounts 2025 filed NBBmicro format · 61 days late
Registered in the Peppol Directory Reachable for e-invoices through 0208:0754509847
2025
Liquidity more than 243 times current ratio 9.86 The current ratio rises from 0.04 to 9.86. Short-term debt falls from €237,494 to €105,046.
Annual accounts 2024 filed PDFmicro format · 27 days late
2024
Weakest financial year net €66,538 ▼27.9% The net result drops to €66,538, the lowest from 2021 to 2025. It recovers the following year.
Equity above €500,000 equity €538,643 ▲14.1% With a profit in every financial year since 2021, equity grows to €538,643.
Annual accounts 2023 filed PDFmicro format · 47 days late
2023
Annual accounts 2022 filed PDFmicro format · 30 days late
2022
Annual accounts 2021 filed PDFmicro format · 31 days late
2020
resigns as directorGeneral meeting of 21-09-20202 points ▸
- General meeting, 21-09-2020
- Director resignation,
First establishment A.Jans Pharma, Kloosterstraat 11, Bree
IncorporationFounding capital of €176,000, 176 shares · Founded by · (director) and (director) appointed · published on 18-09-20207 points ▸
- Founder,
- Founding capital, €176,000, 176 shares
- holds 176 shares
- Registered office clause, 3960Bree, Kloosterstraat11
- Board rule, 2
- Director appointment, (director (not named in the articles))
- Director appointment, (director (not named in the articles))
- The deed holds 7 more points.
Financial milestones sit on the financial year-end date, not the filing date.
Sources: Publications in the Belgian Official GazetteFilings with the National Bank